TLR3 and neoplasm: The enhanced TLR3 response stimulates an amplified IFN type I response, resulting in a significant lymphocyte infiltration, shifting the ratio to favor CD8+ effector cells over immunosuppressive CD8+ T-regulatory (Treg) cells within the tumor microenvironment.